One month of dual antiplatelet therapy (DAPT) followed by potent P2Y12 inhibitor monotherapy was associated with a reduction in major bleeding without increasing MACCE among patients with ACS undergoing PCI with DES. https://ja.ma/3ZseVqC
Rythmologue CH ARGENTEUIL et Chef de service Cardio CH Nanterre
3dtrès instructif pour les patients fragiles à haut risque hémorragique.